Efficacy and Safety of Rifaximin in Treating MAFLD
Efficacy and Safety of Rifaximin in Treating MAFLD
Recruiting · NCT07185932 · Registry updated 2025-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rifaximin in Treating MAFLD | Metabolic-associated Fatty Liver Disease | Recruiting | Early phase 1 | 2025-09-22 | NCT07185932 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Changzheng Hospital | 79 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changzheng Hospital, Naval Medical University, shanghai, China | Shanghai | China | 1 |